Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
Daxor will showcase its FDA 510(k)-cleared next-generation Blood Volume Analyzer at the HFSA Annual Scientific Meeting in Phoenix, October 9-12, 2026, including a Device Day appearance and Booth #803 demonstrations. The new platform operates 3x faster than the predecessor BVA-100, requires 50% less blood per test, and delivers >95% measurement accuracy.
Key figures
- Speed improvement
- 3x faster than BVA-100 predecessor
- Blood draw reduction
- 50% less blood
- Measurement accuracy
- >95%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.